U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT07562958) titled 'Fertility Impact of Microplastics - Advancing Countermeasures and Tracking' on April 11.
Brief Summary: FERTIMPACT is a prospective clinical study based on the hypothesis that exposure to micro- and nanoplastics (MNPs) is associated with impaired reproductive function. The study will quantify MNPs in human reproductive biospecimens (semen, follicular fluid, endometrial samples, stool and serum) and evaluate their association with clinically relevant fertility parameters, including semen, follicular fluid, and endometrial samples quality, and assisted reproductive technology (ART) outcomes. By integrating biomonitoring with standardize...